214 No socioeconomic differences in overall survival seen in patients with advanced ovarian cancer where parity of access to treatment and cytoreductive outcomes can be achieved
214 No socioeconomic differences in overall survival seen in patients with advanced ovarian cancer where parity of access to treatment and cytoreductive outcomes can be achieved